Hepatic steatosis: a risk factor for increased COVID-19 prevalence and severity—a computed tomography studyOriginal Research Article Published on 2021-07-122022-10-31 Journal: Egyptian Liver Journal [Category] COVID-19, [키워드] affected age Chest CT Comorbidities Computed tomography Control control group controls COVID COVID-19 COVID-19 severity CT chest diabetes disorder evaluate Fatty liver Frequency greater hepatic hepatic steatosis hypertension include individual individuals liver male men Negative PCR non-infected obesity participant Patient PCR-positive Pneumonia positive positive PCR Prevalence prevalent Research Result risk factor severe disease severity shown steatosis subjects syndrome women [DOI] 10.1186/s43066-021-00131-6 PMC 바로가기 [Article Type] Original Research Article
The role of natural killer cells in liver inflammationReview Published on 2021-07-072022-10-29 Journal: Seminars in immunopathology [Category] COVID-19, [키워드] Activation Autoimmune Autoimmune liver disease Autoimmunity Cell cytotoxic function disease effective Fatty liver fatty liver disease hepatotropic homeostasis immune immune response immune tolerance immunological Inflammation Inflammatory involved liver Liver disease liver diseases Liver inflammation natural natural killer cell NK cell NK cells pro-inflammatory promote subset tolerogenic response Treatment understanding Viral hepatitis viral infection [DOI] 10.1007/s00281-021-00877-6 PMC 바로가기 [Article Type] Review
Risk of severe illness of COVID‐19 patients with NAFLD and increased NAFLD fibrosis scoresResearch Article Published on 2021-07-022022-10-30 Journal: Journal of Clinical Laboratory Analysis [Category] COVID-19, MERS, [키워드] 95% CI 95% confidence interval absence association cause Chronic Liver Diseases Clinical outcome concurrent COVID‐19 COVID‐19 patient COVID‐19 patients COVID‐19 determine diabete diagnosed disease evaluate Fatty liver fibrosis hepatic higher risk independent risk factor index indicated knowledge Liver fibrosis male median age Multivariate analysis NAFLD NAFLD patient non‐alcoholic fatty liver disease Odds ratio Patient Result severe illness severity was used [DOI] 10.1002/jcla.23880 PMC 바로가기 [Article Type] Research Article
COVID‐19 and the liver – Lessons learnedSupplement Article Published on 2021-06-212022-10-30 Journal: Liver international : official journal of the Inte [Category] COVID-19, MERS, SARS, [키워드] Activation Autoimmune Biochemistry Characteristics characterized cirrhosis coronavirus disease Course COVID‐19 Critical current cytokine production Cytopathic effect disease disease severity elevated Epidemiology Fatty liver hepatocyte high risk hospitalized patient hypoxic Immune cell Immunosuppressive medication include increase in indicated individual Inflammatory response lesson liver Liver damage Liver disease Liver function Liver function test Liver injury Liver transplantation marker mechanism outcome pathological mechanism Patient receiving severity stages susceptibility virus [DOI] 10.1111/liv.14854 PMC 바로가기 [Article Type] Supplement Article
Pregnancy With SARS-CoV-2 Infection Complicated by Preeclampsia and Acute Fatty Liver of PregnancyObstetrics/Gynecology Published on 2021-06-142022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute fatty liver of pregnancy Acute kidney injury acute respiratory syndrome age approach co-morbidity Complication coronavirus coronavirus disease COVID-19 Diagnosis Fatty liver Infection intensive care Neonatal outcome pandemic preeclampsia Pregnancy Pregnant woman pregnant women reported required SARS-CoV-2 severe disease Spread the disease with COVID-19 women worsening [DOI] 10.7759/cureus.15645 PMC 바로가기 [Article Type] Obstetrics/Gynecology
How does liver steatosis affect diagnostic performance of 2D-SWE.SSI: assessment from aspects of steatosis degree and pathological typesArticle Published on 2021-05-012023-06-13 Journal: European Radiology [Category] B형 간염, [키워드] Elasticity imaging techniques Fatty liver Liver fibrosis [DOI] 10.1007/s00330-020-07288-5
Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19대사 관련 지방간 질환 환자의 간 섬유증은 COVID-19의 불리한 결과에 대한 위험 요소입니다Article Published on 2021-05-012022-09-11 Journal: Digestive and liver disease : official journal of [Category] 바이오마커, [키워드] Acute kidney injury adverse outcome AKI analyzed association AST cohort study Computed tomography computed tomography scan coronavirus coronavirus disease COVID-19 COVID-19 patients Cox regression analysis CT scan determined by disease evaluate Fatty liver fatty liver disease fibrosis Hospital admission hospitalized patient hospitalized patients incidence increased risk inflammatory markers Kaplan-Meier Kaplan-Meier curve Kaplan-Meier curves liver Liver fibrosis liver steatosis Logistic regression analysis Mann-Whitney U mechanical ventilation metabolic Metabolic diseases metabolic dysfunction Mortality NAFLD no differences onset of symptom Patient patients with COVID-19 Platelet Prognosis pulmonary involvement retrospective cohort study risk factor Risk factors SARS-CoV-2 severe coronavirus disease severity scores steatosis t-test Treatment was determined were used with COVID-19 [DOI] 10.1016/j.dld.2021.01.019 PMC 바로가기 [Article Type] Article
The Impact of Increased Fib-4 Score in Patients with Type II Diabetes Mellitus on COVID-19 Disease PrognosisArticle Published on 2021-04-302022-10-30 Journal: Medicina [Category] COVID-19, MERS, SARS, [키워드] 95% CI 95% confidence interval association Clinical outcome coronavirus disease COVD-19 COVID-19 death Diagnosis disease dysfunction evaluated Evidence Fatty liver ferritin FIB-4 fibrosis form high risk Hospital stay hospitalized patient ICU admission Impact Increased independent predictor individual liver Liver fibrosis liver steatosis obesity Odds ratio Participants Patient patients performed Prognosis prognostic Prospective Study Registered reported risk risk stratification score screened statistically significant T2DM Type type II diabete with COVID-19 [DOI] 10.3390/medicina57050434 PMC 바로가기 [Article Type] Article
Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 SeverityImmunology Published on 2021-03-302022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, SARS, [키워드] Adaptive immunity affecting alteration approved Care coronavirus country COVID-19 COVID-19 pandemic disease exacerbated Fatty liver Health immune system Infectious disease Innate innate immune response Innate immunity MAFLD metabolic Mortality NASH obesity pandemic pathology patients potential therapeutic target Prevalence prognostic biomarker progression Research risk SARS-CoV-2 severe COVID-19 Stage susceptible syndrome Treatment type II diabete [DOI] 10.3389/fimmu.2021.651728 PMC 바로가기 [Article Type] Immunology
Hepatic Steatosis, Rather Than Underlying Obesity, Increases the Risk of Infection and Hospitalization for COVID-19Medicine Published on 2021-03-292022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] Affect age Analysis baseline Biomarker BMI body mass index Cohort cohort study COVID-19 COVID-19 test described determine disease disease severity fat Fatty liver fraction Gender healthy hepatic hepatic steatosis Hospitalization Hospitalized increase increased risk individual individuals Infection liver liver fat measure MRI multivariate logistic regression obese obesity participant performed Personalized medicine phenotypic positive positive test result Prospective PROTECT public policy risk factor risk of infection secondary severity tested UK biobank UK Biobank data variable was determined with COVID-19 [DOI] 10.3389/fmed.2021.636637 PMC 바로가기 [Article Type] Medicine